Jury Awards $2.1 Billion in Monsanto Roundup Cancer Lawsuit

A Philadelphia jury has awarded $2.1 billion to a man who claimed that exposure to Monsanto's Roundup weedkiller caused his cancer. This verdict marks one of the largest awards in a series of lawsuits against Bayer, the German conglomerate that acquired Monsanto in 2018. The plaintiff argued that Roundup, which contains the chemical glyphosate, led to his non-Hodgkin's lymphoma.

Bayer has faced numerous legal battles over Roundup, with thousands of similar cases pending across the United States. The company maintains that glyphosate is safe and that the science supports its position. However, the Philadelphia case adds significant pressure on Bayer, as it comes amidst other high-profile losses in court.

The financial impact of the verdict is substantial, with Bayer's stock dropping significantly following the announcement. Analysts are now questioning the future strategy of the company, which has already set aside billions of dollars to settle previous Roundup-related claims.

• Bayer
• Monsanto
• Philadelphia
• Roundup

Detailed Bayer hit with Roundup verdict in US state of Georgia

Georgia jury orders Monsanto parent to pay nearly $2.1 billion in Roundup weedkiller lawsuit

2 weeks ago

- apnews

Ga. jurors award $2.1 billion verdict against Bayer in Roundup lawsuit

2 weeks ago

- washingtonpost

Man who claimed weedkiller caused cancer awarded $2.1bn by US jury

2 weeks ago

- news

Bayer Shares Plunge After U.S. Court Defeat in Roundup Case

2 weeks ago

- wsj